4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-23-014869
SVP, Chief Business Officer sold 6,357 shares at $3.03 ($19,257)
- SVP, Chief Business Officer acquired 60,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Mitchener Stephen · SVP, Chief Business Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-02-28 | Grant or award : show line 1 in the form | +60,000 | 134,670 | D | ||
| 2023-03-01 | Sale : show line 2 in the form | −6,357 | $3.03 | $19,257 | 128,313 | D |
| Open-market sales · 6,357 sh · avg $3.03 · $19,257 | ||||||
Loading xslF345X03/doc4.xml…